Context Matters: The Importance of a Comprehensive Genomic Region When Assessing the Therapeutic Potential of

Dyah W Karjosukarso1, Julia F Kiefmann1, Femke Bukkems1

  • 1Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

PubMed

Insights

Mini/midigene splicing assays using antisense oligonucleotides (AONs) showed surprising efficacy for ABCA4 variants. A maxigene with full genomic context improved AON candidate selection for splicing modulation therapy.

Area of Science:

  • Genetics
  • Molecular Biology
  • Ophthalmology

Background:

  • Splicing modulation therapy, often using antisense oligonucleotides (AONs), is a promising approach for genetic disorders.
  • Assessing AON efficacy typically involves mini/midigene splicing assays.
  • A recurrent variant in the ABCA4 gene (c.768G>T) causes a splicing defect relevant to retinal diseases.

Purpose of the Study:

  • To evaluate the efficacy of 25 AONs targeting the ABCA4 splicing defect.
  • To investigate the impact of genomic context on AON efficacy in splicing assays.
  • To determine the necessity of including proper genetic context in splicing assays for therapeutic assessment.

Main Methods:

  • Testing 25 AONs in a midigene assay containing parts of ABCA4 intron 5, exon 6, and intron 6.
  • Comparing AON efficacy in the midigene assay versus a maxigene assay with extended genomic context (introns 5-11).
  • Corroborating findings with patient-derived retinal cells.

Main Results:

  • Nearly all tested AONs demonstrated high efficacy in the midigene assay, hindering candidate selection.
  • The maxigene assay, incorporating a larger genomic region, successfully differentiated between efficacious and less efficacious AONs.
  • Results from the maxigene assay aligned with observations in patient-derived retinal cells.

Conclusions:

  • The lack of extensive genomic context in mini/midigene assays may overestimate AON efficacy.
  • Including a comprehensive genomic context in splicing assays is crucial for accurately assessing AONs for splicing modulation therapy.
  • Maxigene assays provide a more reliable platform for selecting effective AON candidates for ABCA4-related disorders and potentially other genetic conditions.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.9K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K